PAPER
Shelf-Stable Halo- and Alkoxy-Substituted Pyridylboronic Acids
1037
1H NMR [(CD3)2C(O)–TMS]: δ = 8.59 (d, 1 H, J = 1.8 Hz), 8.03
(dd, 1 H, J = 2.1, 1.8 Hz), 7.18 (s, 2 H, OH), 6.69 (d, 1 H, J = 8.1
Hz), 4.35 (q, 2 H, J = 4.2 Hz), 1.33 (t, 3 H, J = 5.1 Hz).
13C NMR [(CD3)2C(O)–TMS]: δ = 165.56, 153.79, 144.38, 110.16,
61.25, 14.27.
3-(6-Fluoro-pyridin-3-yl)-quinoline (13)
Compound 4 (100 mg, 0.7 mmol), 3-bromoquinoline (199 mg, 1.0
mmol), Pd(PPh3)2Cl2 and Cs2CO3 in dioxane were reacted accord-
ing to the general procedure. The reaction was complete in 67 h. Pu-
rification by column chromatography (CH2Cl2–EtOAc, 1:1) gave
compound 13 as a white solid (91 mg, 57%); mp 126–127 °C.
1H NMR [(CD3)2C(O)–TMS]: δ = 9.12 (d, 1 H, J = 2.4 Hz), 8.60
(m, 1 H), 8.52 (d, 1 H, J = 2.0 Hz), 8.34 (m, 1 H), 7.95 (m, 2 H),
7.68 (m, 1 H), 7.54 (m, 1 H), 7.17 (m, 1 H).
Anal. Calcd for C7H10BFNO2 (167.0): C, 50.35; H, 6.04; N, 8.39.
Found: C, 50.09; H, 6.10; N, 8.26.
2-Methoxy-3-pyridylboronic Acid (8)
To a solution of 2-methoxypyridine (7) (1.2 mL, 11.4 mmol) in an-
hyd THF (10 mL) at 0 °C was added LDA (2.0 M in heptane–THF–
ethylbenzene, 6.9 mL, 13.8 mmol) dropwise. The reaction mixture
was stirred for 3 h at –78 °C, then TMB (2.4 g, 23.2 mmol) was add-
ed dropwise. The mixture was allowed to warm to 20 °C, quenched
with H2O (10 mL) and stirred overnight. Workup as for compound
4 gave 8 as a white solid (235 mg, 13%); mp 143–145 °C.
13C NMR [(CD3)2C(O)–TMS]: δ = 164.94, 162.58, 149.43, 147.99,
146.60, 146.45, 140.86, 140.78, 133.67, 132.25, 132.21, 130.00,
129.77, 129.42, 128.57, 128.09, 127.43, 110.16, 109.78.
Anal. Calcd C14H9FN2 (224.2): C, 74.99; H, 4.05; N, 12.49, Found:
C, 74.54; H, 4.16; N, 12.38.
MS(EI): m/z (%) = 224 (M+, 100).
1H NMR [(CD3)2C(O)–TMS]: δ = 8.24 (dd, 1 H, J = 2.1, 2.1 Hz),
8.12 (dd, 1 H, J = 2.1, 1.8 Hz), 7.10 (s, 2 H, OH), 7.00 (m, 1 H),
3.99 (s, 3 H).
13C NMR [(CD3)2C(O)–TMS]: δ = 168.26, 150.09, 146.70, 118.08,
53.56.
3-(5-Bromo-pyridin-3-yl)-quinoline (14)
Compound 5 (100 mg, 0.4 mmol), 3-bromoquinoline (153 mg, 0.7
mmol), Pd(PPh3)2Cl2 and Cs2CO3 in dioxane were reacted accord-
ing to the general procedure. The reaction was complete in 68 h. Pu-
rification by column chromatography (EtOAc–CH2Cl2, 7:3) gave
compound 14 as a white solid (11 mg, 8%); mp 180–182 °C.
1H NMR (CDCl3–TMS): δ = 9.07 (s, 1 H), 8.86 (s, 1 H), 8.71 (s, 1
H), 8.27 (s, 1 H), 8.11 (d, 2 H, J = 8.0 Hz), 7.86 (d, 1 H, J = 8.5 Hz),
7.73 (t, 1 H, J = 7.0 Hz), 7.58 (t, 1 H, J = 7.5 Hz).
Anal. Calcd for C6H8BNO3 (152.9): C, 47.12; H, 5.27; N, 9.16,
Found: C, 46.78; H, 5.18; N, 8.94.
3-Bromo-6-methoxy-4-pyridylboronic Acid (11)
To a solution of 5-bromo-2-methoxypyridine (9) (727 mg, 3.9
mmol) in anhyd THF (10 mL) at –78 °C was added LDA (2.0 M in
heptane–THF–ethylbenzene, 2.0 mL, 4.0 mmol) dropwise. The re-
action mixture was stirred for 1 h at –78 °C, then TIPB (1.5 g, 7.8
mmol) was added dropwise. The mixture was stirred for 1 h at –78
°C then quenched with H2O (10 mL) and allowed to warm to 20 °C
overnight. Workup as for compound 4 gave 11 as a white solid (351
mg, 39%); mp 97–99 °C.
1H NMR [(CD3)2C(O)–TMS]: δ = 8.16 (s, 1 H), 7.76 (s, 2 H, OH),
6.84 (s, 1 H), 3.85 (s, 3 H)
13C NMR [(CD3)2C(O)–TMS]: δ = 162.79, 147.44, 115.67, 114.92,
53.17.
13C NMR (CDCl3–TMS): δ = 149.20, 147.79, 146.87 (2 C), 145.44,
136.12, 133.10, 129.39, 128.38 (3 C), 127.11, 126.60 (2 C).
MS (EI): m/z (%) = 284 (M+, 100%).
HRMS: m/z calcd for C14H9BrN2, 283.99491; found, 283.99310.
3-(6-Ethoxy-pyridin-3-yl)-quinoline (15)
Compound 6 (12 mg, 0.07 mmol), 3-bromoquinoline (21 mg, 0.1
mmol), Pd(PPh3)2Cl2 and Cs2CO3 in dioxane were reacted accord-
ing to the general procedure. The reaction was complete in 63 h. Pu-
rification by column chromatography (CH2Cl2–EtOAc, 9:1) gave
compound 15 as a white solid (10 mg, 59%); mp 104–105 °C.
1H NMR [(CD3)2C(O)–TMS]: δ = 9.21 (d, 1 H, J = 2.5 Hz), 8.63 (d,
1 H, J = 2.0 Hz), 8.54 (d, 1 H, J = 2.0 Hz), 8.16 (dd, 1 H, J = 2.8,
2.5 Hz), 8.05 (m, 2 H), 7.76 (m, 1 H), 7.64 (m, 1 H), 6.93 (d, 1 H,
J = 8.0 Hz), 4.43 (q, 2 H, J = 7.0 Hz), 1.39 (t, 3 H, J = 7.0 Hz).
Anal. Calcd for C6H7BBrNO3 (231.8): C, 31.08; H, 3.04; N, 6.04.
Found: C, 31.09; H, 2.90; N, 6.00.
3-Bromo-6-ethoxy-4-pyridylboronic Acid (12)
13C NMR [(CD3)2C(O)–TMS]: δ = 164.95, 150.34, 148.58, 146.66,
138.81, 133.38, 131.82 (2C), 130.36 (2C), 129.30, 128.11, 127.87,
122.31, 62.62, 15.18
Following the procedure used for compound 12, 5-bromo-2-ethox-
ypyridine (10) (261 mg, 1.3 mmol), THF (10 mL) and LDA (2.0 M
in heptane–THF–ethylbenzene, 0.8 mL, 1.5 mmol) gave 12 as a
white solid (74 mg, 23%); mp 103–105 °C.
MS(EI): m/z (%) = 250 (M+, 55), 235 (100).
1H NMR [(CD3)2C(O)–TMS]: δ = 8.15 (s, 1 H), 7.70 (s, 2 H, OH),
6.81 (s, 1 H), 4.30 (q, 2 H, J = 7.2 Hz), 1.32 (t, 3 H, J = 6.8 Hz).
HRMS: m/z calcd for C16H14N2O, 250.11061; found, 250.11059.
13C NMR [(CD3)2C(O)–TMS]: δ = 162.48, 147.45, 115.86, 114.67,
3-(2-Methoxy-pyridin-3-yl)-quinoline (16)
Compound 8 (100 mg, 0.7 mmol), 3-bromoquinoline (153 mg, 0.7
mmol), Pd(PPh3)2Cl2 and Cs2CO3 in dioxane were reacted accord-
ing to the general procedure. The reaction was complete in 95 h. Pu-
rification by column chromatography (CH2Cl2–EtOAc, 1:1) gave
compound 15 as a white solid (86 mg, 77%); mp 89–90 °C.
1H NMR [(CD3)2C(O)–TMS]: δ = 9.12 (d, 1 H, J = 2.0 Hz), 8.48 (d,
1 H, J = 2.0 Hz), 8.26 (dd, 1 H, J = 2.0, 2.0 Hz), 8.08 (m, 1 H), 8.01
(m, 1 H), 7.95 (dd, 1 H, J = 2.0, 2.0 Hz), 7.78 (m, 1 H), 7.64 (m, 1
H), 7.16 (m, 1 H), 3.98 (s, 3 H).
61.72, 14.15
Anal. Calcd for C7H9BBrNO3 (245.9): C, 34.20; H, 3.69; N, 5.70.
Found: C, 34.90; H, 3.25; N, 5.90.
Cross-Coupling Reactions; General Procedure
The boronic acid (1.0 equiv.), 3-bromoquinoline (or for compound
18 2-bromo-5-nitrothiophene) (1.2–1.8 equiv), and Pd(PPh3)2Cl2 (5
mol%) were sequentially added to degassed 1,4-dioxane (10 mL)
and the mixture was stirred at 20 °C for 30 min. Degassed aqueous
Cs2CO3 solution (1 M, 3.0 equiv) was added and the reaction mix-
ture was heated under nitrogen at 95 °C until TLC monitoring
showed that the reaction had finished. Solvent was removed in vac-
uo then EtOAc was added and the organic layer was washed with
brine, separated, and dried over MgSO4. The product was purified
by chromatography on a silica gel column.
13C NMR [(CD3)2C(O)–TMS]: δ = 161.21, 151.35, 147.52, 147.03,
139.33, 135.42, 130.25, 129.64, 129.33, 128.44, 128.06, 127.00,
121.40, 117.77, 53.21.
MS(EI): m/z (%) = 236 (M+, 100).
HRMS: m/z calcd for C15H12N2O, 236.09496; found, 236.09500.
Synthesis 2003, No. 7, 1035–1038 ISSN 0039-7881 © Thieme Stuttgart · New York